Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Change in Account Payables: 2010-2013

Historic Change in Account Payables for Capricor Therapeutics (CAPR) over the last 3 years, with Dec 2013 value amounting to $97,512.

  • Capricor Therapeutics' Change in Account Payables fell 113.03% to -$51,818 in Q2 2014 from the same period last year, while for Jun 2014 it was $419,806, marking a year-over-year decrease of 47.56%. This contributed to the annual value of $97,512 for FY2013, which is N/A change from last year.
  • As of FY2013, Capricor Therapeutics' Change in Account Payables stood at $97,512, which was down 7.53% from $105,457 recorded in FY2011.
  • Over the past 5 years, Capricor Therapeutics' Change in Account Payables peaked at $181,752 during FY2010, and registered a low of $97,512 during FY2013.
  • Its 2-year average for Change in Account Payables is $101,484, with a median of $101,484 in 2011.
  • Data for Capricor Therapeutics' Change in Account Payables shows a maximum YoY tumbled of 41.98% (in 2011) over the last 5 years.
  • Over the past 3 years, Capricor Therapeutics' Change in Account Payables (Yearly) stood at $181,752 in 2010, then crashed by 41.98% to $105,457 in 2011, then reached $97,512 in 2013.